Literature DB >> 6987762

Histocompatibility antigens (HLA) and uveitis.

Y Scharf, S Zonis.   

Abstract

The studies of histocompatibility (HLA) antigens have contributed to the understanding of the pathogenesis of uveitis. Acute anterior uveitis is associated with rheumatic disorders such as ankylosing spondylitis. HLA-B 27 antigen is present in 98% of these cases. There are genetic and environmental factors influencing the activity of the disease. HLA-B 27 was found to be associated with 43% of cases of acute anterior uveitis without systemic disease. In juvenile chronic polyarthritis with acute anterior uveitis HLA-B 27 helps in differentiating between ankylosing spondylitis and Still's disease. Specific HLA antigens were also found in other forms of uveitis such as Reiter's disease (HLA-B 27), Behcet's syndrome (HLA-B 5), VKH syndrome (HLA-Bw 22J) and ocular histoplasmosis (HLA-B 7). Despite these new findings, there are still many obscure factors and further studies are required to elucidate the pathogenesis of uveitis and to achieve its prevention.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6987762     DOI: 10.1016/0039-6257(80)90043-0

Source DB:  PubMed          Journal:  Surv Ophthalmol        ISSN: 0039-6257            Impact factor:   6.048


  5 in total

Review 1.  Sarcoidosis.

Authors:  D G Peckham; M A Spiteri
Journal:  Postgrad Med J       Date:  1996-04       Impact factor: 2.401

2.  Acute anterior uveitis, ankylosing spondylitis, back pain, and HLA-B27.

Authors:  A B Beckingsale; J Davies; J M Gibson; A R Rosenthal
Journal:  Br J Ophthalmol       Date:  1984-10       Impact factor: 4.638

Review 3.  Uveitis. A review.

Authors:  C Y Lowder; D H Char
Journal:  West J Med       Date:  1984-03

4.  HLA-B27 frequency and MLC reactions in acute anterior uveitis.

Authors:  K M Saari; J Häkli; J Solja; A Kaakinen; S Seppänen; S Kallio; M Kataja
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1981

Review 5.  Interleukins and cytokine biomarkers in uveitis.

Authors:  S Balamurugan; Dipankar Das; Murat Hasanreisoglu; Brian C Toy; Mashal Akhter; V K Anuradha; Eliza Anthony; Bharat Gurnani; Kirandeep Kaur
Journal:  Indian J Ophthalmol       Date:  2020-09       Impact factor: 1.848

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.